Skip to main content
. 2021 Aug 6;99:108050. doi: 10.1016/j.intimp.2021.108050

Table 3.

Phase 3 and 4 vaccines against COVID-19. (Data was extracted from Gavi. Available online at: https://www.gavi.org/vaccineswork/covid-19-vaccine-race [Last accessed: July 8, 2021]).

Vaccine type Institute Country
Phase 3 vaccines
Inactivated vaccine Beijing institute of biological products China
Inactivated vaccine Wuhan institute of biological products China
Inactivated vaccine Bharat biotech international ltd India
Viral vector vaccine Gamaleya research institute Russia
Viral vector vaccine Janssen/johnson&johnson USA
Protein subunit vaccine Novavax USA
Protein subunit vaccine Anhui zhifei longcom biopharmaceutical & institute of microbiology, chinese academy of sciences China
DNA vaccine Zydus cadila India
Inactivated vaccine Chinese academy of medical sciences China
Inactivated vaccine Research institute for biological safety problems Kazakhstan
RNA vaccine Curevac Germany
Protein subunit vaccine Sanofi pasteur/GSK France
Protein subunit vaccine Instituto finlay de vacunas Cuba
Protein subunit vaccine Vector institute Russia
Protein subunit vaccine The center for genetic engineering and biotechnology of Cuba Cuba
RNA vaccine People's liberation army (pla) academy of military sciences/ suzhou abogen biosciences/walvax biotechnology China
Inactivated vaccine Shenzhen kangtai biological products/ beijing minhai biotechnology co., ltd. China



Phase 4 vaccines
RNA vaccine Moderna USA
Viral vector vaccine Astrazeneca/university of oxford UK
Rna vaccine Pfizer/biontech Germany
Inactivated vaccine Sinovac China